Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.635 USD | -2.84% |
|
-10.95% | -8.63% |
24/06 | Leerink Partners Upgrades Solid Biosciences to Outperform From Market Perform, Price Target is $12 | MT |
21/06 | Top Premarket Gainers | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.63% | 223M | |
+16.56% | 122B | |
+21.50% | 116B | |
+22.18% | 27.03B | |
-21.34% | 20.36B | |
-16.89% | 16.43B | |
-17.97% | 15.91B | |
-44.74% | 15.6B | |
+61.93% | 14.94B | |
+3.43% | 13.59B |
- Stock Market
- Equities
- SLDB Stock
- News Solid Biosciences Inc.
- Transcript : Solid Biosciences Inc., Q3 2020 Earnings Call, Nov 05, 2020